BG106524A - Piperidine quinolyl propyl derivatives and their use as antibacterial means - Google Patents
Piperidine quinolyl propyl derivatives and their use as antibacterial meansInfo
- Publication number
- BG106524A BG106524A BG106524A BG10652402A BG106524A BG 106524 A BG106524 A BG 106524A BG 106524 A BG106524 A BG 106524A BG 10652402 A BG10652402 A BG 10652402A BG 106524 A BG106524 A BG 106524A
- Authority
- BG
- Bulgaria
- Prior art keywords
- piperidine
- quinolyl propyl
- antibacterial means
- propyl derivatives
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
The synthesized compounds are used as active substances for producing means for the treatment of primary bacterial infections. The quinolyl propyl piperidine derivatives have the general formula wherein R1 is hydrogen or halogen atom or hydroxy radical, R'1 is hydrogen atoms or may also mean halogen when R1 is also a halogen atom, Ro is a hydrogen atom, and the meanings of R2, R3 and R4 are given in the description. 11 claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9911679A FR2798656B1 (en) | 1999-09-17 | 1999-09-17 | DERIVATIVES OF QUINOLYL PROPYL PIPERIDINE, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM |
PCT/FR2000/002541 WO2001025227A2 (en) | 1999-09-17 | 2000-09-14 | Quinolyl propyl piperidine derivatives and their use as antibacterial agents |
Publications (1)
Publication Number | Publication Date |
---|---|
BG106524A true BG106524A (en) | 2003-01-31 |
Family
ID=9549990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG106524A BG106524A (en) | 1999-09-17 | 2002-03-15 | Piperidine quinolyl propyl derivatives and their use as antibacterial means |
Country Status (30)
Country | Link |
---|---|
EP (2) | EP1484328B1 (en) |
JP (1) | JP2004527448A (en) |
KR (1) | KR20020038757A (en) |
CN (1) | CN1374959A (en) |
AP (1) | AP2002002459A0 (en) |
AT (1) | ATE284399T1 (en) |
AU (1) | AU7429500A (en) |
BG (1) | BG106524A (en) |
BR (1) | BR0014060A (en) |
CA (1) | CA2383836A1 (en) |
CZ (1) | CZ2002940A3 (en) |
DE (2) | DE60016611T2 (en) |
DZ (1) | DZ3195A1 (en) |
EA (1) | EA005183B1 (en) |
EE (1) | EE200200138A (en) |
FR (1) | FR2798656B1 (en) |
GE (1) | GEP20043223B (en) |
HR (1) | HRP20020214A2 (en) |
HU (1) | HUP0204283A3 (en) |
IL (1) | IL148720A0 (en) |
MA (1) | MA26820A1 (en) |
MX (1) | MXPA02001979A (en) |
NO (1) | NO20021253L (en) |
OA (1) | OA12022A (en) |
PL (1) | PL354809A1 (en) |
SK (1) | SK3632002A3 (en) |
TN (1) | TNSN00184A1 (en) |
WO (1) | WO2001025227A2 (en) |
YU (1) | YU19002A (en) |
ZA (1) | ZA200202073B (en) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9822440D0 (en) | 1998-10-14 | 1998-12-09 | Smithkline Beecham Plc | Medicaments |
GB9917408D0 (en) | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
GB9917406D0 (en) | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
PL366335A1 (en) | 2000-07-26 | 2005-01-24 | Smithkline Beecham P.L.C. | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
GB0031086D0 (en) * | 2000-12-20 | 2001-01-31 | Smithkline Beecham Plc | Medicaments |
GB0101577D0 (en) | 2001-01-22 | 2001-03-07 | Smithkline Beecham Plc | Compounds |
GB0112834D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
GB0112836D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
AU2003239302A1 (en) | 2002-01-29 | 2003-09-02 | Glaxo Group Limited | Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
TW200406410A (en) | 2002-01-29 | 2004-05-01 | Glaxo Group Ltd | Compounds |
TW200406413A (en) | 2002-06-26 | 2004-05-01 | Glaxo Group Ltd | Compounds |
AR040336A1 (en) | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | PIPERIDINE COMPOUND, USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND PROCEDURE TO PREPARE SUCH COMPOUND |
FR2842807A1 (en) * | 2002-07-23 | 2004-01-30 | Aventis Pharma Sa | QUINOLYL PROPYL PIPERIDINE DERIVATIVES, PROCESS AND PREPARATION INTERMEDIATES AND COMPOSITIONS COMPRISING THE SAME |
FR2844270B1 (en) | 2002-09-11 | 2006-05-19 | Aventis Pharma Sa | QUINOLYL PROPYL PIPERIDINE DERIVATIVES, THEIR PROCESS AND PREPARATION INTERMEDIATES AND THE COMPOSITIONS CONTAINING THEM |
FR2844268B1 (en) | 2002-09-11 | 2004-10-22 | Aventis Pharma Sa | QUINOLYL PROPYL PIPERIDINE DERIVATIVES, PROCESSES AND INTERMEDIATES FOR THEIR PREPARATION, AND COMPOSITIONS CONTAINING THEM |
CA2500320A1 (en) * | 2002-10-10 | 2004-04-29 | Morphochem Aktiengesellschaft Fuer Kombinatorische Chemie | Novel compounds with antibacterial activity |
WO2004041210A2 (en) | 2002-11-05 | 2004-05-21 | Smithkline Beecham Corporation | Antibacterial agents |
DE60331849D1 (en) | 2002-11-05 | 2010-05-06 | Glaxosmithkline Llc | ANTIBACTERIAL ACTIVE SUBSTANCES |
EP1567520B1 (en) | 2002-12-04 | 2008-10-15 | Glaxo Group Limited | Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents |
ATE466857T1 (en) * | 2004-10-05 | 2010-05-15 | Actelion Pharmaceuticals Ltd | NEW PIPERIDINE ANTIBIOTICS |
EP1799674B1 (en) * | 2004-10-05 | 2010-05-05 | Actelion Pharmaceuticals Ltd. | New piperidine antibiotics |
JP2008528586A (en) | 2005-01-25 | 2008-07-31 | グラクソ グループ リミテッド | Antibacterial agent |
US7605169B2 (en) | 2005-01-25 | 2009-10-20 | Glaxo Group Limited | Antibacterial agents |
US7592334B2 (en) | 2005-01-25 | 2009-09-22 | Glaxo Group Limited | Antibacterial agents |
EP1845995A4 (en) | 2005-01-25 | 2010-03-03 | Glaxo Group Ltd | Antibacterial agents |
JP2009524643A (en) | 2006-01-26 | 2009-07-02 | アクテリオン ファーマシューティカルズ リミテッド | Tetrahydropyran antibiotics |
JP2009532423A (en) | 2006-04-06 | 2009-09-10 | グラクソ グループ リミテッド | Pyrrolo-quinoxalinone derivatives as antibacterial agents |
GB0613208D0 (en) | 2006-07-03 | 2006-08-09 | Glaxo Group Ltd | Compounds |
EP1992628A1 (en) | 2007-05-18 | 2008-11-19 | Glaxo Group Limited | Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones |
AU2008249745B2 (en) * | 2007-05-09 | 2012-01-12 | Pfizer Inc. | Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials |
EP2080761A1 (en) | 2008-01-18 | 2009-07-22 | Glaxo Group Limited | Compounds |
WO2010043714A1 (en) | 2008-10-17 | 2010-04-22 | Glaxo Group Limited | Tricyclic nitrogen compounds used as antibacterials |
ES2561631T3 (en) | 2009-01-15 | 2016-02-29 | Glaxo Group Limited | Naphthyridine-2 (1H) -one compounds useful as antibacterial agents |
JP6483666B2 (en) * | 2013-10-14 | 2019-03-13 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Selectively substituted quinoline compounds |
EP3182973B1 (en) | 2014-08-22 | 2019-09-18 | GlaxoSmithKline Intellectual Property Development Limited | Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection |
TW201722965A (en) | 2015-08-16 | 2017-07-01 | 葛蘭素史密斯克藍智慧財產發展有限公司 | Compounds for use in antibacterial applications |
EP3889145B1 (en) | 2015-12-17 | 2024-02-21 | Merck Patent GmbH | 8-cyano-5-piperidino-quinolines as tlr7/8 antagonists and their uses for treating immune disorders |
MX2019001096A (en) | 2016-08-08 | 2019-07-04 | Merck Patent Gmbh | Tlr7/8 antagonists and uses thereof. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2717899A (en) * | 1998-01-26 | 1999-08-09 | Smithkline Beecham Plc | Quinoline derivatives as antibacterials |
WO2000043383A1 (en) * | 1999-01-20 | 2000-07-27 | Smithkline Beecham P.L.C. | Piperidinylquinolines as protein tyrosine kinase inhibitors |
-
1999
- 1999-09-17 FR FR9911679A patent/FR2798656B1/en not_active Expired - Fee Related
-
2000
- 2000-09-14 AT AT00962637T patent/ATE284399T1/en not_active IP Right Cessation
- 2000-09-14 JP JP2001528171A patent/JP2004527448A/en active Pending
- 2000-09-14 EP EP04019136A patent/EP1484328B1/en not_active Expired - Lifetime
- 2000-09-14 EA EA200200374A patent/EA005183B1/en not_active IP Right Cessation
- 2000-09-14 HU HU0204283A patent/HUP0204283A3/en unknown
- 2000-09-14 GE GEAP20006413A patent/GEP20043223B/en unknown
- 2000-09-14 AU AU74295/00A patent/AU7429500A/en not_active Abandoned
- 2000-09-14 DE DE60016611T patent/DE60016611T2/en not_active Expired - Fee Related
- 2000-09-14 SK SK363-2002A patent/SK3632002A3/en unknown
- 2000-09-14 CZ CZ2002940A patent/CZ2002940A3/en unknown
- 2000-09-14 BR BR0014060-0A patent/BR0014060A/en not_active IP Right Cessation
- 2000-09-14 IL IL14872000A patent/IL148720A0/en unknown
- 2000-09-14 AP APAP/P/2002/002459A patent/AP2002002459A0/en unknown
- 2000-09-14 WO PCT/FR2000/002541 patent/WO2001025227A2/en not_active Application Discontinuation
- 2000-09-14 KR KR1020027003547A patent/KR20020038757A/en not_active Application Discontinuation
- 2000-09-14 DZ DZ003195A patent/DZ3195A1/en active
- 2000-09-14 PL PL00354809A patent/PL354809A1/en not_active Application Discontinuation
- 2000-09-14 CN CN00813020A patent/CN1374959A/en active Pending
- 2000-09-14 OA OA1200200074A patent/OA12022A/en unknown
- 2000-09-14 EE EEP200200138A patent/EE200200138A/en unknown
- 2000-09-14 YU YU19002A patent/YU19002A/en unknown
- 2000-09-14 CA CA002383836A patent/CA2383836A1/en not_active Abandoned
- 2000-09-14 DE DE60034713T patent/DE60034713T2/en not_active Expired - Fee Related
- 2000-09-14 MX MXPA02001979A patent/MXPA02001979A/en unknown
- 2000-09-14 EP EP00962637A patent/EP1218370B1/en not_active Expired - Lifetime
- 2000-09-15 TN TNTNSN00184A patent/TNSN00184A1/en unknown
-
2002
- 2002-03-11 HR HR20020214A patent/HRP20020214A2/en not_active Application Discontinuation
- 2002-03-13 NO NO20021253A patent/NO20021253L/en not_active Application Discontinuation
- 2002-03-13 ZA ZA200202073A patent/ZA200202073B/en unknown
- 2002-03-14 MA MA26554A patent/MA26820A1/en unknown
- 2002-03-15 BG BG106524A patent/BG106524A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG106524A (en) | Piperidine quinolyl propyl derivatives and their use as antibacterial means | |
AU674477B2 (en) | Heterocyclic-cyclic amine derivatives | |
BG103945A (en) | Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a | |
AU2002216214A1 (en) | Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents | |
BG103947A (en) | Derivatives of 9-oxymerythromycin | |
DE69923849D1 (en) | QUINOLIN-2-ON DERIVATIVES USE AS ANTICROPHOSIS | |
GB9917408D0 (en) | Compounds | |
AU2002314914A1 (en) | Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases | |
AP9801378A0 (en) | 9-amino-3- keto erythromycin derivatives. | |
MY137156A (en) | Dual nk1/nk3 derivatives | |
AU697679B2 (en) | Treatment of tinnitis using neuroprotective agents | |
NO20015172L (en) | 1-methyl-erythromycin derivatives | |
CA2146763A1 (en) | Quinolone and acridinone derivatives for the treatment of urinary incontinence | |
PL358666A1 (en) | 2-hydroxy-mutilin carbamate derivatives for antibacterial use | |
DE69907419D1 (en) | Antitumorwirkstoffe | |
MY133785A (en) | Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias | |
BG105004A (en) | Carbapenem derivatives, utilization thereof and intermediate compounds of the same | |
NO20022123L (en) | Oxoxazole derivatives for use as inhibitors of phosphodiesterase VII | |
EP1121932A4 (en) | Remedies for ocular diseases | |
CA2374902A1 (en) | Aminoalkyl substituted benzopyran derivatives for treating impaired fundic relaxation | |
YU46302A (en) | Substituted pyrroles | |
AP9801235A0 (en) | Erythromycin derivatives. | |
YU19302A (en) | 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use | |
AP9901559A0 (en) | Tricyclic 3-keto derivatives of 6-0-methylerythromycin. | |
MY133140A (en) | N-substituted azabicycloheptane derivatives, their preparation and use |